Cappuccio F P, Markandu N D, Buckley M G, Sugden A L, Sagnella G A, MacGregor G A
Department of Medicine, Charing Cross & Westminster Medical School, London, U.K.
J Endocrinol Invest. 1989 Mar;12(3):205-7. doi: 10.1007/BF03349963.
Plasma levels of atrial natriuretic peptides (ANP) were significantly higher in 7 patients with treated Addison's disease (15.8 +/- 8.8 pg/ml, mean +/- SD) than in 7 control subjects (6.1 +/- 3.8 pg/ml) matched for sex, age, body weight and blood pressure. All subjects were studied on their usual sodium intake and had similar urinary sodium excretions. These findings indicate inappropriately high levels of plasma ANP in patients with treated Addison's disease and are possibly due to the lack of adrenal control on ANP synthesis and/or secretion in these patients.
7例接受治疗的艾迪生病患者的血浆心房利钠肽(ANP)水平(15.8±8.8 pg/ml,均值±标准差)显著高于7例在性别、年龄、体重和血压方面相匹配的对照受试者(6.1±3.8 pg/ml)。所有受试者均按照其日常钠摄入量进行研究,且尿钠排泄量相似。这些发现表明,接受治疗的艾迪生病患者血浆ANP水平异常升高,这可能是由于这些患者缺乏肾上腺对ANP合成和/或分泌的调控。